This country profile provides an overview of the Central African Republic’s progress in reaching those in need of mass NTD treatment based on 2019 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Treatment coverage

Elephantiasis
40%
Blinding trachoma
35%
Intestinal worms
86%
Bilharzia
94%
River blindness
66%
2.25 million people received treatment in the Central African Republic in 2019 2.20 million people did not receive treatment in the Central African Republic in 2019

Elephantiasis

Treatment coverage increased from 31% in 2018 to 40% in 2019.

People needing treatment
4.44m
People receiving treatment
1.78m

Blinding trachoma

Treatment coverage increased from 24% in 2018 to 35% in 2019.

People needing treatment
3.11m
People receiving treatment
1.08m

Intestinal worms

Treatment coverage increased from 35% in 2018 to 86% in 2019.

Pre-sch and school-aged children needing treatment
997k
Pre-school and school-aged children receiving treatment
857k

Bilharzia

Treatment coverage increased from 44% in 2018 to 94% in 2019.

School-aged children needing treatment
478k
School-aged children receiving treatment
448k

River blindness

Treatment coverage increased from 34% in 2018 to 66% in 2019.

People needing treatment
2.61m
People receiving treatment
1.73m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Central African Republic.